HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siok Kun Goh Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

7/2011Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Siok Kun Goh Research Topics

Disease

1Primary Myelofibrosis (Myelosclerosis)
07/2011
1Lymphoma (Lymphomas)
07/2011
1Neoplasms (Cancer)
07/2011
1Colonic Neoplasms (Colon Cancer)
03/2009

Drug/Important Bio-Agent (IBA)

1Histone Deacetylase InhibitorsIBA
07/2011
111- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
07/2011
1Janus Kinase 2IBA
07/2011
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2011
1Tyrosine (L-Tyrosine)FDA Link
07/2011
1N- hydroxy- 3- (2- phenethyl- 1- (2- pyrrolidin- 1- yl- ethyl)- 1H- benzimidazol- 5- yl)acrylamideIBA
03/2009

Therapy/Procedure

1Therapeutics
07/2011